These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 18655368)
21. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer. Boo YJ; Park JM; Kim J; Chae YS; Min BW; Um JW; Moon HY Ann Surg Oncol; 2007 May; 14(5):1703-11. PubMed ID: 17211730 [TBL] [Abstract][Full Text] [Related]
22. The prognostic value of E-cadherin, alpha-, beta- and gamma-catenin in bladder cancer patients who underwent radical cystectomy. Kashibuchi K; Tomita K; Schalken JA; Kume H; Takeuchi T; Kitamura T Int J Urol; 2007 Sep; 14(9):789-94. PubMed ID: 17760743 [TBL] [Abstract][Full Text] [Related]
23. Expression of E-cadherin, beta-catenin and Ki-67 antigen and their reciprocal correlations in fibrosarcomas of soft tissues in dogs. Nowak M; Madej JA; Dziegiel P In Vivo; 2007; 21(5):751-6. PubMed ID: 18019408 [TBL] [Abstract][Full Text] [Related]
24. Microsatellite analysis of the APC gene and immunoexpression of E-cadherin, catenin, and tubulin in esophageal squamous cell carcinoma. Nair KS; Naidoo R; Chetty R Hum Pathol; 2006 Feb; 37(2):125-34. PubMed ID: 16426911 [TBL] [Abstract][Full Text] [Related]
25. Overexpression of osteopontin independently correlates with vascular invasion and poor prognosis in patients with hepatocellular carcinoma. Korita PV; Wakai T; Shirai Y; Matsuda Y; Sakata J; Cui X; Ajioka Y; Hatakeyama K Hum Pathol; 2008 Dec; 39(12):1777-83. PubMed ID: 18701136 [TBL] [Abstract][Full Text] [Related]
26. Adenomatous polyposis coli (APC) protein expression in primary and metastatic serous ovarian carcinoma. Karbova E; Davidson B; Metodiev K; Tropé CG; Nesland JM Int J Surg Pathol; 2002 Jul; 10(3):175-80. PubMed ID: 12232570 [TBL] [Abstract][Full Text] [Related]
27. Clinical factors and biomarkers in ovarian tumors development. Vrabie CD; Petrescu A; Waller M; Dina I Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637 [TBL] [Abstract][Full Text] [Related]
28. Association of E-cadherin and beta-catenin immunoexpression with clinicopathologic features in primary ovarian carcinomas. Faleiro-Rodrigues C; Macedo-Pinto I; Pereira D; Ferreira VM; Lopes CS Hum Pathol; 2004 Jun; 35(6):663-9. PubMed ID: 15188131 [TBL] [Abstract][Full Text] [Related]
29. E-cadherin and beta-catenin expression patterns in malignant melanoma assessed by image analysis. Pećina-Slaus N; Zigmund M; Kusec V; Martić TN; Cacić M; Slaus M J Cutan Pathol; 2007 Mar; 34(3):239-46. PubMed ID: 17302608 [TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical expression of beta-catenin, E-cadherin, cyclin D1 and c-myc in benign trichogenic tumors. Demirkan NC; Bir F; Erdem O; Düzcan E J Cutan Pathol; 2007 Jun; 34(6):467-73. PubMed ID: 17518774 [TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical expression of epidermal growth factor receptor, E-cadherin, and matrix metalloproteinase-9 in ovarian epithelial cancer and relation to patient deaths. Alshenawy HA Ann Diagn Pathol; 2010 Dec; 14(6):387-95. PubMed ID: 21074685 [TBL] [Abstract][Full Text] [Related]
32. Prophylactic oophorectomy: a morphologic and immunohistochemical study. Schlosshauer PW; Cohen CJ; Penault-Llorca F; Miranda CR; Bignon YJ; Dauplat J; Deligdisch L Cancer; 2003 Dec; 98(12):2599-606. PubMed ID: 14669279 [TBL] [Abstract][Full Text] [Related]
33. Hepatocyte growth factor induces invasion and migration of ovarian cancer cells by decreasing the expression of E-cadherin, beta-catenin, and caveolin-1. Hu J; Shao S; Song Y; Zhao J; Dong Y; Gong L; Yang P Anat Rec (Hoboken); 2010 Jul; 293(7):1134-9. PubMed ID: 20583256 [TBL] [Abstract][Full Text] [Related]
34. Abnormal distribution of E-cadherin and beta-catenin in different histologic types of cancer of the uterine cervix. Rodríguez-Sastre MA; González-Maya L; Delgado R; Lizano M; Tsubaki G; Mohar A; García-Carrancá A Gynecol Oncol; 2005 May; 97(2):330-6. PubMed ID: 15863126 [TBL] [Abstract][Full Text] [Related]
35. Expression of cadherin/catenin cell--cell adhesion molecules in a onychomatricoma. Burchette JL; Pham TT; Higgins SP; Cook JL; Soler AP Int J Surg Pathol; 2008 Jul; 16(3):349-53. PubMed ID: 18573792 [TBL] [Abstract][Full Text] [Related]
36. Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma. Guo C; Liu QG; Yang W; Zhang ZL; Yao YM Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):490-6. PubMed ID: 18842495 [TBL] [Abstract][Full Text] [Related]
37. Increased tissue immunoexpression of YKL-40 protein in high grade serous ovarian cancers. Stawerski P; Wągrowska-Danilewicz M; Stasikowska-Kanicka O; Danilewicz M Pathol Res Pract; 2011 Sep; 207(9):573-6. PubMed ID: 21820815 [TBL] [Abstract][Full Text] [Related]
38. E-cadherin and beta-catenin mRNA levels throughout colon cancer progression. Truant SC; Gouyer VP; Leteurtre EA; Zerimech F; Huet GM; Pruvot FR J Surg Res; 2008 Dec; 150(2):212-8. PubMed ID: 18316097 [TBL] [Abstract][Full Text] [Related]
39. Two canine Merkel cell tumours: immunoexpression of c-KIT, E-cadherin, beta-catenin and S100 protein. Gil da Costa RM; Rema A; Pires MA; Gärtner F Vet Dermatol; 2010 Apr; 21(2):198-201. PubMed ID: 19706008 [TBL] [Abstract][Full Text] [Related]
40. Epidermal growth factor receptor expression in serous ovarian carcinoma: an immunohistochemical study with galectin-3 and cyclin D1 and outcome. Brustmann H Int J Gynecol Pathol; 2008 Jul; 27(3):380-9. PubMed ID: 18580315 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]